NCT04706754 Pan-Canadian Lung Cancer Observational Study (PALEOS)
| NCT ID | NCT04706754 |
| Status | Recruiting |
| Phase | — |
| Sponsor | William Osler Health System |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 25,000 participants |
| Start Date | 2020-04-07 |
| Primary Completion | 2040-04-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25,000 participants in total. It began in 2020-04-07 with a primary completion date of 2040-04-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A multicenter, ambispective observational study focusing on patients diagnosed with lung cancer in Canada identified after January 1, 2000 inclusive. This data will be combined with that from deceased patients identified.
Eligibility Criteria
Inclusion Criteria: • Adults aged 18 years or older having a documented lung cancer diagnosis since 2000. Exclusion Criteria: • Patients that decline to provide informed consent.
Contact & Investigator
Parneet Cheema, MD
PRINCIPAL INVESTIGATOR
William Osler Health System
Frequently Asked Questions
Who can join the NCT04706754 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04706754 currently recruiting?
Yes, NCT04706754 is actively recruiting participants. Contact the research team at lynn.vicente@williamoslerhs.ca for enrollment information.
Where is the NCT04706754 trial being conducted?
This trial is being conducted at Brampton, Canada.
Who is sponsoring the NCT04706754 clinical trial?
NCT04706754 is sponsored by William Osler Health System. The principal investigator is Parneet Cheema, MD at William Osler Health System. The trial plans to enroll 25,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.